Q517 - Pharmacy Medication Compounding Contingency Service

SOL #: 36C25626Q0420Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
256-NETWORK CONTRACT OFFICE 16 (36C256)
RIDGELAND, MS, 39157, United States

Place of Performance

Houston, Texas

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Pharmacy Services (Q517)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 23, 2026
2
Last Updated
Mar 4, 2026
3
Submission Deadline
Mar 6, 2026, 6:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Michael E. Debakey VA Medical Center in Houston, TX, is seeking Emergency Contingency Services for Hazardous and Non-Hazardous Medication Compounding. This is a combined synopsis/solicitation issued as an RFQ. The deadline for RFQ submissions has been extended to March 6, 2026, at 12:00 PM CST.

Scope of Work

The requirement is for comprehensive medication compounding services, including the provision of hazardous and non-hazardous agents, IV tubing, and closed system drug transfer devices. Key deliverables involve aseptic compounding of patient-specific orders, with delivery required by 7:30 AM the day after order submission. All compounding, labeling, and dating must comply with USP 797, USP 800, and Federal Law. Contractors must also provide current and future certification reports for sterile compounding areas and hoods, and annually update the "VHA PBM Assessment Guide for Compounded Sterile Preparations." Specific compatibility needs include the Bag Spike Rule, Primary/Secondary IV Set (BD or interchangeable), and In-line Filter requirements.

Contract & Timeline

  • Type: Firm-Fixed-Price, Indefinite-Delivery-Indefinite-Quantity (IDIQ)
  • Period of Performance: One year from the date of award
  • Set-Aside: Unrestricted
  • NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing), Small Business Size Standard: 1,300 Employees
  • PSC Code: Q517 (Pharmacy Services)
  • RFQ Submission Deadline: March 6, 2026, 12:00 PM CST
  • Questions Due: February 25, 2026, 3:00 PM CST
  • Published Date: March 4, 2026 (Amendment)

Evaluation

Award will be made on a Lowest Price Technically Acceptable (LPTA) basis. Evaluation factors include Technical (Offeror's Product, Contingency Plan, and Delivery Requirements) and Price (assessed for reasonableness, completeness, and fairness).

Submission Details

Quotes must be submitted electronically via email to the Contract Specialist, Eugene Jackson, at Eugene.Jackson2@va.gov. Offerors must include a statement regarding the acceptance of terms and conditions as per FAR 52.212-4. All interested contractors must provide pricing in the "Pricing" column of the PWS. Annual representations and certifications must be completed electronically via SAM.gov.

People

Points of Contact

Eugene JacksonContract SpecialistPRIMARY

Files

Files

Download
Download
Download
View

Versions

Version 2Viewing
Combined Synopsis/Solicitation
Posted: Mar 4, 2026
Version 1
Combined Synopsis/Solicitation
Posted: Feb 23, 2026
View
Q517 - Pharmacy Medication Compounding Contingency Service | GovScope